Abivax
(ABVX.FP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 272 | 251 | 273 | 279 | 245 |
| Accounts receivable | -4,588 | 4,448 | -2,161 | 3,226 | -2,658 |
| Accounts payable and accrued liabilities | -27,998 | 984 | 12,754 | 169 | 13,666 |
| Other Working Capital | -2,075 | 6,450 | 9,011 | 4,184 | 10,284 |
| Other Operating Activity | -36,894 | -45,473 | -53,155 | -41,372 | -56,920 |
| Operating Cash Flow | $-71,283 | $-33,340 | $-33,278 | $-33,514 | $-35,383 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 8 | -19 | -44 | -93 | -311 |
| Net Acquisitions | 40 | 22 | 18 | 0 | 0 |
| Purchase Of Investment | N/A | N/A | -6 | N/A | N/A |
| Other Investing Activity | 3,232 | 184 | 1,114 | 649 | 2,059 |
| Investing Cash Flow | $3,280 | $187 | $1,082 | $556 | $1,748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 0 | -600 |
| Debt Repayment | -5,735 | -6,913 | -6,123 | -2,242 | -2,314 |
| Common Stock Issued | N/A | N/A | N/A | -132 | N/A |
| Other Financing Activity | 609,196 | -1,854 | -1,714 | -3,452 | -3,375 |
| Financing Cash Flow | $603,461 | $-8,767 | $-7,837 | $-5,826 | $-6,289 |
| Exchange Rate Effect | -7,155 | -1,173 | -612 | 2,553 | -1,941 |
| Beginning Cash Position | 60,946 | 103,576 | 144,221 | 180,451 | 222,317 |
| End Cash Position | 589,703 | 60,946 | 103,576 | 144,221 | 180,451 |
| Net Cash Flow | $535,912 | $-41,457 | $-40,033 | $-38,783 | $-39,925 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,283 | -33,340 | -33,278 | -33,514 | -35,383 |
| Capital Expenditure | N/A | -19 | -44 | -93 | -311 |
| Free Cash Flow | -71,283 | -33,359 | -33,322 | -33,607 | -35,694 |